Together, these findings from NP-based and [18F]-insulin studies propose innovative nasal delivery systems for insulin, providing a solid foundation for further clinical evaluation and potential treatment of Alzheimer's disease. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.